At a Glance: Departmental Evaluation Plan for the Public Health Agency of Canada, 2021-22 to 2025-26
Download in PDF format
(194 KB, 5 pages)
Published: 2021-06-28
The Office of Audit and Evaluation (OAE) Departmental Evaluation Plan for PHAC describes the Program Evaluation Division's scheduled work for the five-year period from 2021-22 to 2025-26. The Plan was developed to meet PHAC's commitments under the Policy on Results (2016), which requires that each department prepare a five-year plan, annually updated.
The projects included in this Evaluation Plan were selected to ensure full coverage of all Grant and Contribution spending over $5 million annually over a five-year period, prior commitments in Treasury Board Submissions, the information needs of program management, and program risks, and optimal use of resources. The Departmental Results Framework (DRF), program inventory, and performance information profiles developed by PHAC have formed the basis for this plan.
The COVID-19 pandemic continues to have a significant impact on the work of the Public Health Agency of Canada (PHAC) as it remains at the forefront of the Government of Canada's response. To be respectful of the need for branches to focus on the response, and to respond to other oversight reviews such as those led by the Office of the Auditor General and the Standing Committee on Health, OAE reprioritized work and, as necessary and where possible, shifted the timing of planned evaluations.
The present Departmental Evaluation Plan (DEP) reflects the response of OAE to these circumstances, by developing a plan that ensures that OAE focuses its efforts and resources on emerging priorities while continuing to meet our reporting commitments under the Financial Administration Act (FAA). Please note that the current version of the plan does not account for organizational changes that are currently underway at the Agency which have not yet been finalized. This would include branch responsibility for certain activities that have been affected by the COVID-19 response, as well as any enhancement in those activities. Any changes in the proposed evaluation schedule as a result of enhanced COVID-19 activities will be captured in the 2022-23 to 2026-27 Departmental Evaluation Plan.
Planning for Evaluation
Over the next five years, the OAE plans to conduct 36 evaluations that involve PHAC: 26 will focus exclusively on PHAC activities and two will examine the activities of both PHAC and Health Canada. The remaining eight projects are horizontal evaluations led by other government departments or agencies. A yearly breakdown is provided in Table 1 below. Table 2 outlines the direct program spending (DPS) by core responsibility for all scheduled evaluations for the next five years.
| 2021-22 | 2022-23 | 2023-24 | 2024-25 | 2025-26 | Total | |
|---|---|---|---|---|---|---|
| PHAC | 5 | 4 | 6 | 7 | 4 | 26 |
| PHAC and HC | 1 | 1 | 0 | 0 | 0 | 2 |
| Horizontal (OGD-led) | 1 | 3 | 2 | 1 | 1 | 8 |
| Total | 7 | 8 | 8 | 8 | 5 | 36 |
| Program | Evaluations planned in the next five years | Fiscal year of approval | 2021-22 spending covered by evaluation ($)Footnote 1 | Rationale for not evaluating program or spending |
|---|---|---|---|---|
| Core Responsibility - Health Promotion and Chronic Disease Prevention | ||||
| Health Promotion ($235,283,465) |
Aboriginal Head Start in Urban and Northern Communities | 2021-22 | $33,347,831 | N/A |
| Strategy to Prevent and Address Gender-based Violence | 2021-22 | - | N/A | |
| Autism Spectrum Disorder Initiatives | 2022-23 | $3,991,997 | N/A | |
| Canadian Drug & Substances Strategy (including opioids and drug overdose crisis in Canada) | 2022-23 | $2,080,000 | N/A | |
| Action Plan for Official Languages 2018-2023: Investing in Our Future | 2022-23 | $2,088,475 | N/A | |
| Strategy to Prevent and Address Gender-based Violence | 2023-24 | $9,458,339 | N/A | |
| Aging and Seniors | 2023-24 | $13,252,692 | N/A | |
| Pan-Canadian Suicide Prevention Service | 2023-24 | $6,693,007 | N/A | |
| Indigenous Early Learning and Child Care Initiative | 2023-24 | $3,756,552 | N/A | |
| Supporting the Health of Survivors of Family Violence | 2024-25 | $6,250,000 | N/A | |
| Mental Health Promotion Innovation Fund | 2024-25 | $4,947,000 | N/A | |
| Nutrition North Canada | 2024-25 | $335,000 | N/A | |
| Maternal and Child Health Programs | 2025-26 | $99,159,767 | N/A | |
| Oral Health | N/A | $0 | Low Need: Low materiality and evaluation was conducted within the last seven years (2016-17) | |
| Border and Travel Health and Isolation sites (COVID-19) | N/A | $49,922,805 | The timing of this evaluation will be determined in an upcoming version of the DEP. | |
| Chronic Disease Prevention ($33,473,193) |
Health Portfolio's Tobacco and Vaping Activities | 2021-22 | $4,407,926 | N/A |
| ParticipACTION | 2023-24 | $5,000,000 | N/A | |
| Healthy Canadians and Communities Fund | 2024-25 | $23,860,267 | N/A | |
| Office of International Affairs | 2025-26 | $205,000 | N/A | |
| Evidence for Health Promotion, and Chronic Disease and Injury Prevention ($63,450,175) |
Evidence for Health Promotion Chronic Disease and Injury Prevention (including CPHO Report, CCDR) | 2021-22 | $46,169,438 | N/A |
| Strategy to Prevent and Address Gender-based Violence | 2021-22 | - | N/A | |
| Fetal Alcohol Spectrum Disorder (FASD) Initiatives | 2022-23 | $1,499,000 | N/A | |
| Autism Spectrum Disorder Initiatives | 2022-23 | $94,288 | N/A | |
| Canadian Drug & Substances Strategy (including opioids and drug overdose crisis in Canada) | 2022-23 | $2,823,138 | N/A | |
| Canadian Task Force on Preventative Health Care | 2022-23 | - | N/A | |
| Cannabis Program | 2022-23 | $447,985 | N/A | |
| National Collaborating Centres | 2023-24 | $3,281,002 | N/A | |
| Strategy to Prevent and Address Gender-based Violence | 2023-24 | $242,383 | N/A | |
| Aging and Seniors | 2023-24 | $2,540,727 | N/A | |
| Pan-Canadian Suicide Prevention Service | 2023-24 | $94,219 | N/A | |
| Healthy Canadians and Communities Fund | 2024-25 | $4,279,000 | N/A | |
| Mental Health of Black Canadians Program | 2024-25 | $1,928,995 | N/A | |
| Nutrition North Canada | 2024-25 | $50,000 | N/A | |
| Core Responsibility - Infectious Disease Prevention and Control | ||||
| Laboratory Science Leadership and Services ($275,382,930) |
Foodborne and Waterborne Enteric Diseases | 2022-23 | $443,600 | N/A |
| Border and Travel Health Program | 2023-24 | $10,882,981 | N/A | |
| Emergency Preparedness and Response | 2024-25 | $255,067,031 | N/A | |
| Immunization and Respiratory Infectious Diseases | 2024-25 | $1,630,090 | N/A | |
| Genomics Research and Development Initiative (GRDI) | 2025-26 | $1,564,604 | N/A | |
| Infectious Disease and Climate Change | 2025-26 | $1,116,689 | N/A | |
| Sero-Surveillance (COVID-19) | N/A | $4,677,935 | The timing of this evaluation will be determined in an upcoming version of the DEP. | |
| Communicable Diseases and Infection Control ($224,111,078) |
Tuberculosis | 2021-22 | - | N/A |
| Blood Safety (Canadian Blood Services Contribution Programs and PHAC Blood Safety Program) | 2022-23 | $1,694,000 | N/A | |
| Canadian Drug & Substances Strategy (including opioids and drug overdose crisis in Canada) | 2022-23 | $7,456,000 | N/A | |
| Sexually Transmitted and Blood-Borne Infections | 2023-24 | $23,061,758 | N/A | |
| National Collaborating Centres | 2023-24 | $1,093,666 | N/A | |
| Health Care-Associated Infections | 2024-25 | $95,646,010 | N/A | |
| Office of International Affairs | 2025-26 | $825,000 | N/A | |
| Sero-Surveillance (COVID-19) | N/A | $94,334,644 | The timing of this evaluation will be determined in an upcoming version of the DEP. | |
| Vaccination ($5,477,195,896) |
Immunization and Respiratory Infectious Diseases | 2024-25 | $5,477,195,896 | N/A |
| Foodborne and Zoonotic Diseases ($23,406,696) |
PHAC's Activities for the Federal Framework on Lyme Disease and Action Plan | 2021-22 | - | N/A |
| Foodborne and Waterborne Enteric Diseases | 2022-23 | $17,224,135 | N/A | |
| National Collaborating Centres | 2023-24 | $1,093,666 | N/A | |
| Infectious Disease and Climate Change | 2025-26 | $4,938,895 | N/A | |
| Office of International Affairs | 2025-26 | $150,000 | N/A | |
| Core Responsibility - Health Security | ||||
| Emergency Preparedness and Response ($1,924,302,614) |
National Collaborating Centres | 2023-24 | $1,093,666 | N/A |
| Emergency Preparedness and Response | 2024-25 | $1,923,208,948 | N/A | |
| Biosecurity ($13,329,078) |
Human Pathogens and Toxins Regulatory Framework | 2021-22 | $7,244,483 | N/A |
| Biosecurity | 2025-26 | $6,084,595 | N/A | |
| Border Health Security ($179,730,375) |
Border and Travel Health Program | 2023-24 | $179,730,375 | N/A |
Footnote
|
||||
Page details
- Date modified: